WO2009069643A1 - ３－｛５－［４－（シクロペンチルオキシ）－２－ヒドロキシベンゾイル］－２－［（３－ヒドロキシ－１，２－ベンズイソオキサゾール－６－イル）メトキシ］フェニル｝プロピオン酸またはその塩を含有する固体分散体またはその組成物 - Google Patents

３－｛５－［４－（シクロペンチルオキシ）－２－ヒドロキシベンゾイル］－２－［（３－ヒドロキシ－１，２－ベンズイソオキサゾール－６－イル）メトキシ］フェニル｝プロピオン酸またはその塩を含有する固体分散体またはその組成物 Download PDF

Info

Publication number
WO2009069643A1
WO2009069643A1 PCT/JP2008/071425 JP2008071425W WO2009069643A1 WO 2009069643 A1 WO2009069643 A1 WO 2009069643A1 JP 2008071425 W JP2008071425 W JP 2008071425W WO 2009069643 A1 WO2009069643 A1 WO 2009069643A1
Authority
WO
WIPO (PCT)
Prior art keywords
solid dispersion
composition
benzisoxazol
hydroxybenzoyl
cyclopentyloxy
Prior art date
Application number
PCT/JP2008/071425
Other languages
English (en)
French (fr)
Inventor
Sahoe Kakuda
Tatsuhito Yahata
Original Assignee
Toyama Chemical Co., Ltd.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Toyama Chemical Co., Ltd. filed Critical Toyama Chemical Co., Ltd.
Priority to JP2009543823A priority Critical patent/JP5615554B2/ja
Publication of WO2009069643A1 publication Critical patent/WO2009069643A1/ja

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D261/00—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings
    • C07D261/20—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings condensed with carbocyclic rings or ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/32—Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/141—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
    • A61K9/146—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with organic macromolecular compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Inorganic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

　３－｛５－［４－（シクロペンチルオキシ）－２－ヒドロキシベンゾイル］－２－［（３－ヒドロキシ－１，２－ベンズイソオキサゾール６－イル）メトキシ］フェニル｝プロピオン酸またはその塩、およびポリビニルピロリドンを含有する固体分散体またはその組成物は、中性領域でのＴ－５２２４の溶解性を改善、維持し、消化管吸収を向上させた経口用医薬組成物として有用である。
PCT/JP2008/071425 2007-11-27 2008-11-26 ３－｛５－［４－（シクロペンチルオキシ）－２－ヒドロキシベンゾイル］－２－［（３－ヒドロキシ－１，２－ベンズイソオキサゾール－６－イル）メトキシ］フェニル｝プロピオン酸またはその塩を含有する固体分散体またはその組成物 WO2009069643A1 (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2009543823A JP5615554B2 (ja) 2007-11-27 2008-11-26 ３−｛５−［４−（シクロペンチルオキシ）−２−ヒドロキシベンゾイル］−２−［（３−ヒドロキシ−１，２−ベンズイソオキサゾール−６−イル）メトキシ］フェニル｝プロピオン酸またはその塩を含有する固体分散体の組成物

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2007305851 2007-11-27
JP2007-305851 2007-11-27

Publications (1)

Publication Number Publication Date
WO2009069643A1 true WO2009069643A1 (ja) 2009-06-04

Family

ID=40678538

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/JP2008/071425 WO2009069643A1 (ja) 2007-11-27 2008-11-26 ３－｛５－［４－（シクロペンチルオキシ）－２－ヒドロキシベンゾイル］－２－［（３－ヒドロキシ－１，２－ベンズイソオキサゾール－６－イル）メトキシ］フェニル｝プロピオン酸またはその塩を含有する固体分散体またはその組成物

Country Status (2)

Country Link
JP (1) JP5615554B2 (ja)
WO (1) WO2009069643A1 (ja)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2017175792A1 (ja) * 2016-04-06 2017-10-12 アステラス製薬株式会社 速溶出性三次元造形物、速溶出性三次元造形物用フィラメント及び速溶出性三次元造形物用材料

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS55129221A (en) * 1979-03-29 1980-10-06 Kaken Pharmaceut Co Ltd Preparation of oral preparation containing hardly soluble medicine
JPS5942313A (ja) * 1982-09-01 1984-03-08 Teijin Ltd ポリビニルポリピロリドンを用いた製剤
JPS60190723A (ja) * 1984-03-09 1985-09-28 Yamanouchi Pharmaceut Co Ltd 難溶性薬物の溶解速度向上方法
WO2003042150A1 (fr) * 2001-11-16 2003-05-22 Toyama Chemical Co., Ltd. Nouveaux derives de benzophenone ou sels de ceux-ci

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS55129221A (en) * 1979-03-29 1980-10-06 Kaken Pharmaceut Co Ltd Preparation of oral preparation containing hardly soluble medicine
JPS5942313A (ja) * 1982-09-01 1984-03-08 Teijin Ltd ポリビニルポリピロリドンを用いた製剤
JPS60190723A (ja) * 1984-03-09 1985-09-28 Yamanouchi Pharmaceut Co Ltd 難溶性薬物の溶解速度向上方法
WO2003042150A1 (fr) * 2001-11-16 2003-05-22 Toyama Chemical Co., Ltd. Nouveaux derives de benzophenone ou sels de ceux-ci

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2017175792A1 (ja) * 2016-04-06 2017-10-12 アステラス製薬株式会社 速溶出性三次元造形物、速溶出性三次元造形物用フィラメント及び速溶出性三次元造形物用材料
JPWO2017175792A1 (ja) * 2016-04-06 2019-02-14 アステラス製薬株式会社 速溶出性三次元造形物、速溶出性三次元造形物用フィラメント及び速溶出性三次元造形物用材料

Also Published As

Publication number Publication date
JP5615554B2 (ja) 2014-10-29
JPWO2009069643A1 (ja) 2011-04-14

Similar Documents

Publication Publication Date Title
WO2006114415A3 (de) Physiologisch verträgliche salze von 3-[(2-{[4-(hexyloxycarbonylamino-imino-methyl)-phenylamino]-methyl}-1-methyl-1h-benzimidazol-5-carbonyl)-pyridin-2-yl-amino]-propionsäure-ethylester
HK1213316A1 (zh) 用於含有 二氯苯氧基 乙酸鹽的除草製劑的相容劑
ZA200802636B (en) Amino-5-[4-(difluoromethoxy)phenyl]-5-phenylimidazolone compounds as inhibitors of the beta-secretase (BACE)
IL195417A0 (en) Oral composition comprising 3-[5-[4-(cyclopenthyloxy)-2-hydroxybenzoyl]-2-[(3-hydroxy-1,2-benzisoxazol-6-yl) methoxy]phenyl]propionic acid or salt thereof
AU2008229327A8 (en) Amino-5-[substituted-4-(difluoromethoxy)phenyl]-5- phenylimidazolone compounds as beta-secretase inhibitors
AU2005328028A8 (en) Composition for adjuvant containing poly-gamma-glutamic acid
WO2008090066A3 (en) Stabilization of uv-sensitive active ingredients
WO2011053938A8 (en) Methods and compositions for treating cancer
IL189375A (en) Derivatives 1-Heterocyclicsulfonyl-3-Aminomethyl-5- (hetero-) aryl-1-h- Pyrol
EP1756042B8 (en) Substituted methyl aryl or heteroaryl amide compounds
WO2009031642A1 (ja) 医薬組成物
WO2008059029A3 (en) New polymorphs of ethyl 3-[(2-{[4-(hexyloxycarbonylamino-imino-methyl)-phenylamino]-methyl}-1-methyl-1h-benzimidazole-5-carbonyl)-pyridin-2-yl-amino]-propionate
EP1796641A4 (en) NEW FORMULATION, OMEPRAZOL ANTAZIDA COMPLEX WITH IMMEDIATE RELEASE FOR THE RAPID AND CONTINUOUS SUPPRESSION OF MAGIC ACID
HK1100408A1 (en) Oxadiazolone derivatives as ppar delta agonists
WO2006002077A3 (en) Stable pharmaceutical formulations of benzimidazole compounds
IL184885A0 (en) 7-{4-[2-(2,6-dihydro-4-methylphenoxy)ethoxyl]phenyl}-3,9-diazabicyclo[3.3.31]non-6-ene-s-carboxylic acid cyclopropyl-(2,3-dimethylbenzyd amide as inhibitors of renin for the treatment of hypertension
WO2010055119A3 (en) Pharmaceutical composition comprising pimobendan
WO2006107062A3 (en) Benzimidazole derivative and use as angiotensin ii antagonist
WO2005123049A3 (en) A pharmaceutical composition for increasing the mitochondrial genesis
EP2042494A4 (en) 2,4,5-TRISUBSTITUTED THIAZOL COMPOUNDS, METHOD OF MANUFACTURE, PHARMACEUTICAL COMPOSITIONS AND MEDICAL APPLICATIONS THEREOF
WO2009020137A1 (ja) アミノピラゾールアミド誘導体
IL179346A0 (en) 3-(4-(2-dihydroisoxazol-3-ylpyridin-5-yl)phenyl)-5-triazol-1-ylmethyloxazolidin-2-one derivatives as mao inhibitors for the treatment of bacterial infections
WO2005097787A3 (fr) Derives de benzothiazoles capables de moduler l’activite des cdk et leur utilisation comme agents anticancereux
WO2007065846A3 (de) Verwendung von polyvinyllactam-polyoxyalkylen-blockcopolymeren als solubilisatoren für in wasser schwerlösliche verbindungen
EP1773307B8 (en) Compound formulations of 2-amino-1,3-propanediol compounds

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 08855354

Country of ref document: EP

Kind code of ref document: A1

WWE Wipo information: entry into national phase

Ref document number: 2009543823

Country of ref document: JP

NENP Non-entry into the national phase

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 08855354

Country of ref document: EP

Kind code of ref document: A1